Comment on: Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study
Journal of Antimicrobial Chemotherapy · 03.06.2026 · 81 (7)
DOI: 10.1093/jac/dkag208 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 17.06.2026. Verfasst von Francisco González und 2 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hospital Clínico de la Universidad de Chile, Dr. Carlos Lorca Tobar 999, Independencia, Santiago, Chile. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Internal Medicine Department, Hospital Clínico de la Universidad de Chile, Dr. Carlos Lorca Tobar 999, Independencia, Santiago, Chile.
Zitieren
APA
González, F., Chávez, S., & Miranda, F. (2026). Comment on: Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study. Journal of Antimicrobial Chemotherapy, 81(7). https://doi.org/10.1093/jac/dkag208
Vancouver
González F, Chávez S, Miranda F. Comment on: Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study. Journal of Antimicrobial Chemotherapy. 2026;81(7). doi:10.1093/jac/dkag208
BibTeX
@article{Gonzlez2026,
author = {González, Francisco and Chávez, Sebastián and Miranda, Fabián},
title = {Comment on: Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
volume = {81},
number = {7},
doi = {10.1093/jac/dkag208}
}
EUVIMED